The effects of acute and extended monoamine oxidase inhibition upon 5-hydroxyindoles in maturing mouse brain.
1. Mice of four ages between newborn and adult were exposed to the monoamine oxidase inhibitor amiflamine both acutely and in an extended (5 day) regimen. Brains were then assayed at various times following amiflamine for changes in the levels of serotonin (5-HT, 5-hydroxytryptamine) and 5-hydroxyindole acetic acid (5-HIAA). 2. Although both metabolites initially changed as might be expected, with 5-HT elevating and 5-HIAA decreasing, the younger brains recovered their 5-HT levels slower than older brains and eventually young brains had levels of 5-HIAA that were in excess of normal. At some times both metabolites were in excess of normal at younger ages. 3. These results are compared to changes seen with the 5-HT uptake inhibitor citalopram and it is concluded that in young brain 5-HIAA levels lack firm regulatory control and are not passive reflections of 5-HT changes.
Baker
P C
PC
Department of Biology, Cleveland State University, OH 44115.
Hoff
K M
KM
D000375:Aging / Q000378:metabolism; D000818:Animals; D000831:Animals, Newborn / Q000378:metabolism; D001921:Brain / Q000254:growth & development*; D001923:Brain Chemistry / Q000187:drug effects*; D001933:Brain Stem / Q000187:drug effects / Q000378:metabolism; D015283:Citalopram / Q000494:pharmacology; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D007211:Indoles / Q000378:metabolism*; D051379:Mice; D008815:Mice, Inbred Strains; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D010627:Phenethylamines / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism
D007211:Indoles; D008996:Monoamine Oxidase Inhibitors; D010627:Phenethylamines; D015283:Citalopram; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; C031466:amiflamine